30

Shanghai Kaibao Pharmaceutical

300039 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

4.64CNY-0.11 (-2.32%)

Price History

Full chart

Market Stats

Previous Close4.75
Open4.75
Day Range4.63 – 4.76
52-Week Range4.02 – 6.64
Volume10.47M
Market Cap5.54B
P/E (TTM)21.20
Forward P/E17.27
EPS0.25
Dividend Yield2.45%
Beta0.17
50-Day Avg5.51
200-Day Avg5.69

About

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, including Thiopronine for injection and Thiopronine enteric-coated tablets. In addition, the company provides Astragalus and Ginseng Capsules for the treatment of cardiovascular and cerebrovascular diseases. Further, it offers diclofenac sodium enteric-coated tablets; artificial bezoar metronidazole capsules; Mai'an granules; Loquat cough granules that clears the lungs, relieves cough, and reduces phlegm; compound danshen tablets; Tongmai granules to promote blood circulation and unblocks meridians; pediatric pharyngeal granules; stroke rejuvenation pills; and Xiao Chai Hu granules which relieves exterior syndromes, clears heat, soothes the liver, and harmonizes the stomach. Further, the company provides Alopecia areata; Bear bile drops that clears heat, calms the liver, and improves eyesight, as well as used for infantile convulsions and sore throat; and Shanhaidan capsules. Shanghai Kaibao Pharmaceutical CO.,Ltd was founded in 2000 and is based in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yingbin Zhou
  • Employees1.20K
  • HeadquartersNo. 88 Chengpu Road, Shanghai, China, 201401, China
  • Websitehttps://www.xykb.com

Leadership

  • Mr. Yingbin ZhouGM & Director · b. 1978
  • Mr. You Long ChenFinancial Director · b. 1975
  • Mr. Jianzhong LiuDeputy GM & Non-Independent Director · b. 1973
  • Mr. Liwang RenBoard Secretary & Non-Independent Director · b. 1970
  • Mr. Ying Jun ZhuDeputy General Manager · b. 1970
  • Ya Ru LiAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue166.45M258.05M387.39M458.89M603.41M819.97M1.09B1.32B1.62B1.40B1.50B1.57B1.50B1.42B908.01M1.10B1.12B1.59B1.47B1.15B
Growth (%)-+55.03%+50.12%+18.46%+31.49%+35.89%+32.92%+21.40%+22.49%-13.89%+7.26%+4.86%-4.41%-5.44%-36.01%+21.21%+1.66%+42.47%-7.57%-21.76%
Cost of Revenue27.56M45.73M69.60M78.29M107.53M149.01M185.10M204.36M269.09M250.50M282.12M290.55M263.50M252.02M180.55M234.10M247.85M311.82M272.96M222.04M
Gross Profit138.90M212.33M317.78M380.60M495.88M670.95M904.82M1.12B1.35B1.15B1.22B1.28B1.24B1.17B727.46M866.48M871.00M1.28B1.20B930.62M
Gross Margin83.44%82.28%82.03%82.94%82.18%81.83%83.02%84.56%83.40%82.05%81.16%81.49%82.44%82.24%80.12%78.73%77.85%80.44%81.47%80.74%
Operating Expense121.02M172.51M257.96M311.89M382.28M510.52M661.33M764.84M941.89M817.37M890.02M946.76M962.24M865.17M593.04M694.65M642.63M899.28M762.11M658.19M
Operating Income17.87M39.81M59.82M68.71M113.60M160.43M243.50M354.01M409.86M327.91M325.01M332.61M274.93M301.84M134.42M171.83M228.37M382.96M438.25M272.44M
Operating Margin10.74%15.43%15.44%14.97%18.83%19.57%22.34%26.75%25.29%23.49%21.71%21.19%18.32%21.27%14.80%15.61%20.41%24.02%29.75%23.64%
EBITDA23.03M46.82M75.21M88.93M160.18M220.02M271.18M406.80M481.67M388.05M384.43M376.34M322.68M349.44M172.93M203.66M258.03M421.18M469.75M357.17M
EBITDA Margin13.83%18.14%19.42%19.38%26.55%26.83%24.88%30.74%29.72%27.80%25.68%23.97%21.50%24.63%19.04%18.50%23.06%26.42%31.88%30.99%
Net Income20.87M44.81M57.65M68.67M123.70M167.56M242.19M318.82M351.92M281.65M282.61M272.30M226.81M250.99M106.12M140.11M190.80M327.87M375.58M278.58M
Net Income Margin12.54%17.36%14.88%14.96%20.50%20.44%22.22%24.09%21.71%20.18%18.88%17.35%15.11%17.69%11.69%12.73%17.05%20.57%25.49%24.17%
R&D----22.21M29.07M39.73M50.92M59.49M58.78M53.39M64.69M47.50M54.56M59.12M79.32M52.97M95.87M99.79M88.27M
R&D as % of Total Revenue----3.68%3.55%3.64%3.85%3.67%4.21%3.57%4.12%3.17%3.85%6.51%7.21%4.73%6.01%6.77%7.66%
Interest Expense687.67K843.85K1.93M3.14M362.23K43.27K96.87K121.35K20.76M2.39M191.27K278.03K286.34K151.10K769.93K148.50K127.32K118.55K149.36K98.73K
Interest Expense % of Total Revenue0.41%0.33%0.50%0.68%0.06%0.01%0.01%0.01%1.28%0.17%0.01%0.02%0.02%0.01%0.08%0.01%0.01%0.01%0.01%0.01%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets109.03M161.61M229.88M1.35B1.37B1.45B1.56B1.77B2.12B2.43B2.53B2.68B2.75B2.84B2.88B3.36B4.26B4.58B4.52B4.78B
Total Liabilities71.80M84.64M102.95M199.20M133.39M117.97M142.29M164.72M232.72M421.16M327.61M314.26M262.26M273.01M298.96M310.90M498.24M546.82M415.45M359.64M
Total Equity37.24M75.08M126.92M1.15B1.24B1.33B1.42B1.61B1.88B2.01B2.20B2.37B2.49B2.57B2.58B3.04B3.76B4.03B4.10B4.42B
Cash5.74M11.31M29.91M1.01B832.91M796.97M841.68M814.01M816.63M902.39M701.62M582.00M547.05M809.52M1.31B1.34B694.69M601.94M593.31M980.71M
Total Debt6.50M-19.30M118.50M----30.00M53.71M28.79M16.00M95.00K-35.72M7.73M9.10M4.29M5.42M-
Net Debt759.04K-11.31M-10.61M-895.56M-832.91M-796.97M-841.68M-814.01M-786.63M-848.68M-672.83M-566.00M-546.96M-809.52M-1.27B-1.34B-685.59M-601.94M-587.89M-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow19.70M23.27M18.70M52.74M19.79M98.31M243.32M270.23M282.38M327.08M314.88M245.76M262.36M334.09M250.65M126.08M376.42M382.66M278.95M230.74M
Investing Cash Flow-11.74M-4.61M-13.15M-125.70M-51.01M-65.50M-52.15M-168.28M-208.74M-105.27M-435.32M-221.91M-174.04M-600.75M65.21M-83.51M-285.37M-198.63M-33.43M-
Financing Cash Flow-5.98M-13.09M13.05M1.06B-149.92M-68.75M-146.46M-129.62M-71.02M-139.18M-106.23M-118.05M-123.27M-223.84M-69.39M-69.37M-52.30M-62.76M-99.23M-
Capital Expenditure11.74M4.62M11.28M125.70M51.01M68.85M52.21M118.28M68.74M50.40M27.03M49.24M26.07M15.46M13.94M42.55M31.62M29.08M140.52M27.04M
Free Cash Flow7.96M18.65M7.41M-72.97M-31.22M29.46M191.12M151.95M213.64M276.68M287.85M196.51M236.29M318.63M236.71M83.53M344.80M353.59M138.43M203.70M
Dividends Paid4.78M7.79M21.25M30.35M33.24M70.14M157.82M131.52M136.78M130.31M82.43M107.15M107.15M106.42M104.60M31.38M52.30M62.76M104.64M136.03M
FCF to OCF40.42%80.15%39.64%-138.36%-157.77%29.96%78.54%56.23%75.66%84.59%91.42%79.96%90.06%95.37%94.44%66.25%91.60%92.40%49.62%88.28%
Dividend Paid to FCF60.02%41.79%286.71%-41.59%-106.48%238.13%82.58%86.55%64.02%47.10%28.64%54.52%45.35%33.40%44.19%37.57%15.17%17.75%75.59%66.78%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 10, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Oct 20, 2014Feb 26, 2015Apr 21, 2015Aug 18, 2015Oct 22, 2015Feb 26, 2016Apr 25, 2016Aug 7, 2016Oct 25, 2016Feb 27, 2017Apr 20, 2017Aug 17, 2017Oct 24, 2017Apr 18, 2018Aug 8, 2018Oct 25, 2018Apr 23, 2019Aug 22, 2019Oct 25, 2019Apr 21, 2020Aug 26, 2020Oct 29, 2020Apr 23, 2021Aug 26, 2021Oct 28, 2021Apr 28, 2022Aug 16, 2022Oct 26, 2022Apr 25, 2023Aug 9, 2023Oct 20, 2023Jun 5, 2024Aug 29, 2024Oct 25, 2024Jun 5, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------0.06---------------------------------------------
EPS Actual0.020.050.050.020.030.050.040.030.050.070.060.050.130.090.080.070.070.100.090.070.080.090.060.030.080.100.060.020.080.100.070.090.080.050.070.080.050.040.020.030.050.020.030.060.020.030.080.050.060.130.050.070.080.040.060.090.060.04
Surprise------------116.67%---------------------------------------------
Timing------------After-hours-----Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market--------------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap5.54B
Enterprise Value4.43B
Trailing P/E21.20
Forward P/E17.27
PEG Ratio0.00
Price / Sales5.48
Price / Book1.27
EPS0.25
Book Value4.10
Revenue (TTM)1.01B
Gross Profit (TTM)810.65M
EBITDA274.76M
Profit Margin25.58%
Operating Margin19.62%
Return on Equity6.04%
Return on Assets3.26%
Shares Outstanding1.05B
Shares Float636.02M
Beta0.17
Dividend Yield2.45%
Dividend Rate0.13
Payout Ratio52.61%

Dividends

20261×
0.10May 29, 2026
20252×
0.03Nov 27, 20250.10May 29, 2025
20241×
0.10Jun 19, 2024
20231×
0.06May 26, 2023
20221×
0.05Jun 16, 2022
20211×
0.03Jun 9, 2021
20201×
0.10Jun 12, 2020
20191×
0.10May 30, 2019
20181×
0.10May 23, 2018
20171×
0.10Sep 18, 2017
20161×
0.08May 18, 2016
20151×
0.12Apr 30, 2015
20141×
0.15Apr 2, 2014
20131×
0.12Apr 2, 2013
20121×
0.15Apr 26, 2012
20111×
0.07Apr 29, 2011
20101×
0.00Apr 26, 2010

Stock Splits

  • May 10, 201713:10
  • Apr 30, 201513:10
  • Apr 2, 201412:10
  • Apr 2, 201320:10
  • Apr 29, 201115:10
  • Apr 26, 20101.6:1